This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Top Analyst Reports for Thermo Fisher, Eaton & Palo Alto
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Eaton Corporation plc (ETN) and Palo Alto Networks, Inc. (PANW).
ETNNegative Net Change YUMPositive Net Change TMOPositive Net Change MFCPositive Net Change PANWNegative Net Change KDPPositive Net Change
computers industrial-products medical-devices
Baxter (BAX) Recovers After Life2000 Ventilation Systems Recall
by Zacks Equity Research
Baxter (BAX) recalls Life2000 ventilators due to damaged battery charger dongles, posing a risk of device failure
ECLNegative Net Change UHSPositive Net Change BAXNegative Net Change DVANegative Net Change
medical medical-devices
Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital
by Zacks Equity Research
Smith & Nephew (SNN) eyes future growth as Cevian Capital purchases a 5% stake in the company.
ECLNegative Net Change UHSPositive Net Change SNNPositive Net Change DVANegative Net Change
medical medical-devices
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
by Zacks Equity Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
ECLNegative Net Change FMSPositive Net Change DXCMNegative Net Change GKOSNegative Net Change
medical medical-devices
Should You Hold STERIS (STE) Stock Now? Here's What to Consider
by Zacks Equity Research
STERIS' (STE) Healthcare business and strong rebound prospects of the AST segment appear encouraging. However, macroeconomic concerns remain a challenge.
RMDPositive Net Change STENegative Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
by Zacks Equity Research
BD's (BDX) robust product portfolio raises optimism about the stock.
ECLNegative Net Change BDXNegative Net Change SYKNegative Net Change DVANegative Net Change
medical medical-devices
Hims & Hers (HIMS) Gains 37.7% in Three Months: What's Next?
by Debanjana Dey
Hims & Hers (HIMS) is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.
ABTNegative Net Change TDOCPositive Net Change HIMSPositive Net Change
medical medical-devices
Masimo (MASI) Fights Politan in a Bid to Retain CEO on Board
by Zacks Equity Research
Will Masimo (MASI) lose its CEO in its fight against activist investor Politan Capital Management? The company's management and employees want Joe Kiani to continue as the CEO.
AAPLNegative Net Change ECLNegative Net Change DVANegative Net Change MASIPositive Net Change
medical medical-devices
DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
by Zacks Equity Research
Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.
ABTNegative Net Change ECLNegative Net Change DVANegative Net Change DXCMNegative Net Change
medical medical-devices
Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial
by Zacks Equity Research
Microbot Medical's (MBOT) LIBERTY Endovascular Robotic System trial expands to Baptist Hospital of Miami, promising advancements in clinical outcomes and endovascular procedures.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change MBOTNegative Net Change
medical medical-devices
Charles River (CRL) Could be an Apt Pick Right Now: Here's Why
by Zacks Equity Research
Investors are optimistic about Charles River (CRL) due to its business performance and strategic buyouts.
RMDPositive Net Change CRLNegative Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
Here's Why Staying Invested in Neogen (NEOG) Could be Beneficial
by Zacks Equity Research
Neogen (NEOG) instills optimism among investors with its strategic progress and a string of product launches.
RMDPositive Net Change NEOGPositive Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
by Zacks Equity Research
Cardinal Health (CAH) recalls its procedure kits that contain plastic syringes manufactured by a Chinese manufacturer, Jiangsu Shenli.
ECLNegative Net Change DVANegative Net Change CAHPositive Net Change MMSINegative Net Change
medical medical-devices
Lucid Diagnostics (LUCD) Reports Positive ESOGUARD BE-1 Data
by Zacks Equity Research
Lucid Diagnostic's (LUCD) ESOGUARD BE-1 study data shows high sensitivity and negative predictive value for the EsoGuard test, enhancing early detection of esophageal precancer in a screening population.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change LUCDNo Net Change
medical medical-devices
Hologic (HOLX) Moves Up 2% in a Week: Time to Consider Buying?
by Moumi Mondal
Hologic's (HOLX) fundamental strength and cheaper valuation make it a great new addition to the portfolio.
BDXNegative Net Change HOLXNegative Net Change QGENPositive Net Change
earnings-outlook medical medical-devices
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
by Zacks Equity Research
DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change RDNTNegative Net Change
medical medical-devices
KORU Medical's (KRMD) FreedomEdge Gets Regulatory Nod in Japan
by Zacks Equity Research
KORU Medical (KRMD) announces the receipt of regulatory clearance for its FreedomEdge System in Japan.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change KRMDNegative Net Change
medical medical-devices
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
by Zacks Equity Research
Merit Medical's (MMSI) latest asset acquisition is likely to expand its endoscopy portfolio with a minimally-invasive solution for GERD patients, thereby improving patient outcomes.
ECLNegative Net Change SYKNegative Net Change DVANegative Net Change MMSINegative Net Change
medical medical-devices
IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod
by Zacks Equity Research
IceCure Medical's (ICCM) XSense Cryoablation System receives FDA approval, marking a pivotal step in minimally-invasive tumor treatment across multiple medical fields
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change ICCMNegative Net Change
medical medical-devices
Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs
by Zacks Equity Research
Thermo Fisher (TMO) has launched biobased solutions to help reduce the climate impact on the manufacturing of therapies.
TMOPositive Net Change RMDPositive Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
by Zacks Equity Research
Revvity's (RVTY) strong product portfolio raises optimism about the stock.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change RVTYPositive Net Change
medical medical-devices
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
by Zacks Equity Research
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change GKOSNegative Net Change
medical medical-devices
Avantor (AVTR) Launches Solutions for Gene Therapy Harvest
by Zacks Equity Research
Avantor's (AVTR) solutions are intended to provide gene therapy manufacturers with sustainable and efficient alternatives to traditional methods, thus improving viral particle harvest and quality
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change AVTRPositive Net Change
medical medical-devices
Masimo's (MASI) WI Sport Wearable Gets a New Powerful Feature
by Zacks Equity Research
Masimo (MASI) announces Sleep Halo, a new feature for its Masimo W1 Sport advanced health tracking wearable.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change MASIPositive Net Change
medical medical-devices
GE Healthcare (GEHC) Enters Partnership to Boost MRI Technology
by Zacks Equity Research
GE Healthcare's (GEHC) alliance is likely to establish an Innovative MRI Research and Development center to advance MRI innovation and patient care
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change GEHCPositive Net Change
medical medical-devices